Ionis Pharmaceuticals (IONS) enters pact with Bicycle Therapeutics (BCYC) aimed at further advancing LICA technology
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 3/28/2024
Go back to Ionis Pharmaceuticals (IONS) enters pact with Bicycle Therapeutics (BCYC) aimed at further advancing LICA technology
July 15, 2021 7:58 AM EDT
Canaccord Genuity analyst Arlinda Lee raised the price target on Bicycle Therapeutics (NASDAQ: BCYC) to $40.00 (from $36.00) while maintaining a Buy rating.
The analyst commented, "Yesterday, following Ionis Pharmaceuticals' (ION-NASDAQ) exercise of its option to a worldwide exclusive license to transferrin receptor (TfR1) Bicycles... More